1. What are blood clots and thrombots
A blood clot, medically known as a thrombus, is a mass formed by the aggregation of blood components, primarily platelets and fibrin, that can obstruct blood flow inside veins or arteries. While clotting is a crucial process to prevent excessive bleeding after injury, abnormal clot formation within intact blood vessels can be dangerous. Such clots can partially or completely block circulation, depriving tissues of oxygen and nutrients.
When a thrombus forms in the deep veins of the legs, it is called deep vein thrombosis (DVT), which can cause swelling and pain. If a piece of this clot dislodges and travels through the bloodstream, it can lodge in the lungs, causing a pulmonary embolism—a potentially fatal emergency. Clots in the coronary arteries can trigger heart attacks, while those in cerebral vessels may result in strokes. Recognizing these conditions early is vital for prompt treatment.
2. Medications linked to clot risks
Certain medications have been identified as increasing the risk of blood clots, leading to regulatory warnings, usage restrictions, or recalls in many countries. The risk is especially significant in patients who have underlying cardiovascular risk factors.
The most notable categories of medications associated with elevated thrombosis risk include:
- Hormonal contraceptives: Some formulations, particularly third-generation combined oral contraceptives containing specific progestins, have a higher propensity to increase clotting risk compared to older types.
- Anti-inflammatory drugs: Certain nonsteroidal anti-inflammatory drugs (NSAIDs) may increase cardiovascular risks, including clot formation, especially when used long-term.
- Appetite suppressants and diet pills: Some weight-loss medications have been linked to clotting events and are under scrutiny or withdrawal in various regions.
- Medications related to COVID-19: Rare clotting events have been reported with certain COVID-19 treatments and vaccines, leading to ongoing safety monitoring and updated guidance.
Health authorities such as the FDA and EMA have issued guidance to minimize risk, including screening patients before prescribing these drugs and advising regular monitoring during treatment. Patients with pre-existing conditions such as hypertension, obesity, diabetes, or a history of smoking require particular caution when using these medications.
